Abstract: A method of treating hyperhidrosis in a mammalian subject comprising: a) providing a composition comprising a pharmaceutically acceptable vehicle and from about 1.0% to about 25% of a compound having the formula: and b) topically administering the composition to skin of an area of a mammalian subject suffering from hyperhidosis, before bedtime, such that, compared to untreated, baseline conditions, sweat production is reduced by at least about 25% for at least about six (6) hours.

Abstract: The present invention provides a gel composition having improved texture in use. A gel composition consisting of an organosiloxane derivative represented by the following formula (1) or (3), a monohydric aliphatic alcohol having 10 to 30 carbon atoms, and water.

Abstract: A floral fragrance composition for use as a replacement for 3-(4-tertbutylphenyl)-2-methylpropanal (LILIAL®) that is a primary perfuming ingredient composition that includes a first perfuming ingredient of (2,5-dimethyl-2,3-dihydro-IH-inden-2-yl)methanol (LILYFLORE®) in an amount of 5 to 25% by weight; a second perfuming ingredient of a dimethyl-5-indanyl propanal compound in an amount of 0.2 to 10% by weight; and one or more secondary perfuming ingredients including at least one of 3-methyl-5-phenylpentanal, decanal, octanal, cuminic aldehyde, cuminic alcohol, carvone, tetrahydro-2-isobutyl-4-methyl-4(2H)-pyranol, or cis-7-P-menthanol.

Abstract: The present invention pertains to a method of counteracting malodor by introducing a malodor counteracting effective amount of novel cyclohexanol compounds, wherein the compounds are represented by the following formula: an isomer or a mixture of isomers thereof, wherein one of R and R? represents hydrogen with the other representing a C1-C6 linear, branched or cyclic alkyl, alkenyl, alkynyl or aromatic group; and one of the dashed lines represents a carbon-carbon single bond with the other representing a carbon-carbon double bond.

Abstract: A cosmetic product includes a water-in-oil emulsion containing: a) at least one cosmetic active ingredient, b) at least one water-in-oil emulsifier, c) at least one non-ionic polyalkylene glycol ether having a HLB value >7, d) at least one C8-C16 isoparaffin, and also including at least one propellant and an aerosol dispensing device. The emulsion has a high stability, a reduced susceptibility to corrosion, a good cosmetic effect and reduced formation of deposits during the application thereof.

Abstract: A formulation for a 100% natural non-aerosol air freshener infused with vitamins. The formulation may further include plant material known to have naturally occurring fungicidal, bactericidal, disinfectant, germicidal, antiseptic, antibiotic and/or antimicrobial properties. Also, a method of preparing a formulation for a 100% natural non-aerosol air freshener infused with vitamins.

Abstract: The present invention relates to a deodorant composition containing (a) a polyphenol compound or a plant extract containing a polyphenol compound, (b) a basic substance, and (c) a metal salt. The deodorant composition of the present invention is capable of providing a deodorizing effect in a short period of time when it is applied to a malodor source, is capable of providing an excellent deodorizing activity and is also excellent in the store stability.

Abstract: Disclosed are compositions and methods for treating a patient with a pharmaceutically active agent other than insulin selected from the group consisting of peptides, peptidomimetics, and proteins, wherein the pharmaceutical composition is in the form of an emulsified nasal spray comprising: a macrocyclic permeation enhancer, a liquid carrier comprising water, and a therapeutically effective amount of a pharmaceutically active agent other than insulin selected from the group consisting of peptides, peptidomimetics, and proteins; wherein the macrocyclic permeation enhancer is a Hsieh enhancer emulsified in the liquid carrier.

Abstract: The present invention is a method to quantify biomarkers. The method uses an X-ray fluorescence spectrometer to perform an X-ray fluorescence analysis on the sample to obtain spectral features derived from the biomarker; and quantifying the X-ray fluorescence signal of the biomarker.

Abstract: The invention relates to the nontherapeutic cosmetic use of at least one cannabinoid compound chosen from the compounds corresponding to general formula (I): and also the geometric isomers and optical isomers thereof, the cosmetically acceptable acid or base salts thereof, and the hydrates thereof; in which compounds of formula (I): R1 represents a hydrogen atom or a C1-C30 alkyl group; it being possible for said alkyl group to be optionally substituted with a hydroxyl (OH) group; R2 represents a halogen atom or a group chosen from hydroxyl, thiol (SH), and amino optionally substituted with one or two C1-C6 alkyl groups; R3 and R4 form, together with the carbon atom which bears them, an oxo group or else R3 and R4 represent a hydrogen atom; R5 represents a hydrogen atom or a C1-C6 alkyl group; X represents a heteroatom chosen from oxygen and sulfur atoms and the divalent group —N(R6)—, with R6 representing a hydrogen atom or a C1-C6 alkyl group; represents a single or double bond; n is 1, 2 or 3, prefe

Abstract: Transparent antiperspirant compositions in the form of a water-in-oil emulsion containing a balanced mixture of selected oil components and emulsifiers, thereby improving the antiperspirant effect of the compositions.

Abstract: Deodorant formulations are provided. The formulations all commonly include magnesium oxide, zinc oxide and as a disinfecting agent, potassium chloride and/or potassium sulphate. The combination provides long lasting odor protection since the disinfectant destroys odor causing microorganisms. The formulations all contain natural ingredients and the absence of petroleum based or related synthetic compounds contributes to the efficacy of the formulations.

Abstract: The present invention provides an improved deodorant formulation having good efficacy and excellent stability. The deodorant formulation comprises propanediol combined with zinc ricinoleate, grapefruit seed extract, and sodium bicarbonate as the principal deodorizing actives. The combination of these deodorizing active ingredients results in a formulation with strong efficacy which lasts at least 24 hours. The deodorant formulation also displays improved stability when formed into a solid stick product. These features combined provide for an improved deodorant formulation having excellent features of efficacy and stability.

Abstract: A lubricating deodorant for ostomy pouches in the form of an aqueous solution which contains both a water-soluble lubricating agent and a compatible water-soluble complexing agent capable of complexing with and neutralizing the odor-causing molecules of fecal matter. Other surfactants, preservatives, humectants and pH-adjusting agents may also be included. The method of using such a lubricating deodorant solution is also disclosed.

Abstract: Wax compositions derived from metathesized natural oils and amines and methods of making wax compositions from metathesized natural oils and amines are provided. The wax compositions comprise amidated metathesized natural oils formed from a metathesized natural oil and at least one amine. The methods comprise providing an amine and providing a metathesized natural oil. The methods further comprise mixing the amine and the metathesized natural oil in the presence of a basic catalyst or heat, causing a reaction between the amine and metathesized natural oil, therein forming the amidated metathesized natural oil.

Abstract: The present invention provides a deodorant formulation having improved efficacy and stability. The deodorant formulation comprises propanediol, ethylhexylglycerin, and grapefruit seed extract as the principal deodorizing actives. The combination of these deodorizing active ingredients results in a formulation with strong efficacy. The deodorant formulation of the invention may further be formed into a stable solid stick product in accordance with the methods outlined herein.

Abstract: The present invention relates to a pharmaceutical composition in form of emulsion or microemulsion and the use thereof as aid during endoscopic procedures in which it is injected in a target tissue in order to form a cushion. More in details, the invention relates to a method for performing an endoscopic procedure, which comprises injecting said pharmaceutical composition in form of emulsion or microemulsion in a target tissue of a patient, in order to form a cushion, which cushion is then optionally subjected to an endoscopic surgical procedure, such as a resection.

Abstract: A method of treating hyperhidrosis in a mammalian subject comprising: a) providing a composition comprising a pharmaceutically acceptable vehicle and from about 1.0% to about 25% of a compound having the formula: and b) topically administering the composition to skin of an area of a mammalian subject suffering from hyperhidosis, before bedtime, such that, compared to untreated, baseline conditions, sweat production is reduced by at least about 25% for at least about six (6) hours.

Abstract: Provided are a novel ?-glucuronidase inhibitor including a compound selected from a macrocyclic ketone, a ketone, a macrocyclic lactone, a macrocyclic oxalactone, an ester, an aldehyde, an alcohol, and a terpene of specific kinds, and an environmental hygiene product and a sanitary product each containing the ?-glucuronidase inhibitor. Also provided are a composition for suppressing the generation of urine odor and a method of suppressing the generation of urine odor each using a ?-glucuronidase inhibitor.

Abstract: A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol, and PPG-1-PEG-9 lauryl glycol ether. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti-bacterial activity and reducing the expression of pro-inflammatory mediators.

Abstract: Methods for making antiperspirant products in the form of emulsions are provided, wherein the emulsion comprises a continuous water-immiscible phase and a disperse aqueous phase comprising an antiperspirant active. The method comprises the steps of providing a water-immiscible liquid, providing an aqueous solution comprising an antiperspirant active, preparing an emulsion comprising a continuous phase including the water-immiscible liquid and a disperse phase including the aqueous solution, heating the emulsion to a temperature between about 60° C. and about 110° C., providing a structurant that is at least partially dissolved, adding the heated emulsion to the at least partially dissolved structurant to form an emulsified antiperspirant composition, and transferring the emulsified antiperspirant into a dispensing container within about 2 hours of initiating the heating step.

Abstract: An antiperspirant composition may include an aqueous carrier; and at least 4 to 7 weight percent of an aluminum and/or aluminum-zirconium antiperspirant active containing at least a Peak 4 specie. An antiperspirant composition may also include an aqueous carrier; and an aluminum and/or aluminum-zirconium antiperspirant active containing at least a Peak 4 specie, wherein the antiperspirant active contains less than 3 area percent Peak 1 and/or Peak 2 species from an HPLC chromatograph of the antiperspirant composition.

Abstract: A composition for reduced scar formation of wounds includes hydrolyzed collagen and one or more supplemental ingredients, including, lipoic acid, a zinc component, and a glucosamine component. The composition may facilitate inhibition of scar formation during wound healing. The composition may be used, for example, as a topical dressing for a wound, including, an acute or chronic wound.

Abstract: The invention provides a cosmetic composition for reducing facial perspiration. The facial antiperspiration balm is a homogeneous mixture of a cosmetic gel and a cosmetic cream. The balm has a lowered amount of the active agent, moisturizes and protects the skin, and provides a pleasant feeling.

Abstract: The invention relates to a cosmetic formulation with improved effectiveness and reduced stickiness, comprising at least one activated aluminum antiperspirant active ingredient, at least one alpha-hydroxycarboxylic acid and water.

Abstract: Materials and apparatus are provided that include an enhanced evaporative mechanism. A solid antiperspirant composition includes an antiperspirant agent disposed within the solid antiperspirant composition. Further, the solid antiperspirant composition includes an enhanced evaporative component disposed within the solid antiperspirant composition. The enhanced evaporative component includes a spreading agent configured to reduce the surface tension of perspiration molecules.

Abstract: Materials and apparatus are provided that include an enhanced evaporative component. A solid antiperspirant composition includes an antiperspirant agent disposed within the solid antiperspirant composition. Further, the solid antiperspirant composition includes an enhanced evaporative component disposed within the solid antiperspirant composition. The enhanced evaporative component includes a first spreading agent configured to reduce the surface tension of perspiration molecules. The enhanced evaporative component also includes a volatile to increase the volatility of perspiration molecules. Still further, the enhanced evaporative component includes an entrapment material disposed within the solid antiperspirant composition to contain the volatile.

Abstract: Products and methods are disclosed for reducing the production of unwanted odors on the human body.

Abstract: Compounds of general formula (I): R1-Wn-Xm-AA1-AA2-AA3-AA4-AA5-AA6-AA7-AA8-AA9-Yp-Zq-R2 (I) their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, preparation processes, cosmetic or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, neurological, compulsive and/or neuropsychiatric diseases and/or disorders and in processes of treatment and/or care of the skin, hair and/or mucous membranes mediated by neuronal exocytosis.

Abstract: A composition/formula for enhancing the grip of certain athletes and professionals to hold onto or otherwise “stick” on an object like a sports or tool handle or exercise mat/pad. The composition consists of: a magnesium carbonate base to which are added a natural gum rosin, isopropyl alcohol, hydroxyl ethyl cellulose (a plant-based thickener) and certain preferred essential oils (for fragrance). Optionally, some limited quantity of candelilla wax may be blended therein.

Abstract: This innovation is a unique, natural, CONSUMABLE and topical treatment for many of my body's ailments that has helped me in ways other products never did. The anti-bacterial herbs appear to fight the root cause of the many ailments listed, instead of just masking them. It cleansed my pores for acne. I sprayed it in and on my eyes. It gently allowed sebaceous debris, often called eye mucous, to painlessly ooze away from eyelash pores and other eye glands like NO other product I have heard of. It unclogged the micro eyelid circulation, greatly reducing the puffiness we all get with age. Cleaning pores allowed skin to heal itself better, reducing wrinkles and acne scars. It naturally kills bacteria that cause odors under your arms and orally. It is consumable, so it works safely all the way down the back of the tongue where scrappers and chemical washes can't reach.

Abstract: The present invention is directed to water-resistant compositions comprising: a reaction product of at least one lactone compound and at least one amine compound chosen from amino alcohol compounds and alkoxylated amine compounds; and optionally, at least one carrier. These water-resistant compositions are capable of providing or acting as a carrier for delivering benefits to various substrates, for example, keratinous substrates such as skin and hair, while at the same time, imparting durable or long lasting hydrophobicity and/or a protective barrier onto said substrates.

Abstract: Disclosed herein are methods of reducing irritation associated with personal care and cosmetic compositions comprising 1,3-propanediol, wherein the 1,3-propanediol in said personal care or cosmetic composition has a bio-based carbon content of about 1% to 100%. In addition, it is preferred that the 1,3-propanediol be biologically-derived, and wherein upon biodegradation, the biologically-derived 1,3-propanediol contributes no anthropogenic carbon dioxide emissions to the atmosphere.

Abstract: Compounds are used in compositions as antimicrobial agents against microbes, such as for example, Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Aspergillus brasiliensis. Antimicrobial action is obtained by contact of a microorganism with at least one of the compounds of the structure (I); wherein R is a branched or straight chain, saturated or unsaturated hydrocarbyl group with zero or one double bond and a total of from 1 to 11 carbon atoms; R1 is —OH, =0 or —OC(0)CH3 and wherein the compounds of structure (I) contain a total of from 9 to 18 carbon atoms in the compounds.

Abstract: The invention relates to the use of siloxanes for emulsifiers for cosmetic compositions for skin care as well as cosmetic emulsions comprising such emulsifiers. The composition comprises an aminofunctional organopolysiloxane for W/O emulsions, O/W emulsions and multiple emulsions. The emulsions are formed easily, are very stable and needs not to add electrolytes.

Abstract: The present invention relates to the use of at least one dicyclohexylmethanol derivative of the formula (I) as antimicrobial active compound or as anti-acne, antidandruff, deodorant or antiperspirant active compound, to preparations comprising these compounds, and to specific dicyclohexylmethanol derivatives and to a process for the preparation thereof.

Abstract: The present invention relates to the use of at least one cyclohexanol ether derivative of the formula I as antimicrobial active compound or as anti-acne, antidandruff, deodorant or antiperspirant active compound, to preparations comprising these compounds, and to specific cyclohexanol ether derivatives.

Abstract: The present invention pertains to novel 3-(cyclohex-1-en-1-yl)propionates, the unexpected advantageous use thereof in enhancing, improving or modifying the fragrance of perfumes, colognes, toilet waters, fabric care products, personal products, and the like, and the unexpected advantageous use thereof in counteracting malodors.

Abstract: Compounds of general formula (I): Ri—Wn—Xm-AAi-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 (I) their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, preparation processes, cosmetic and/or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, pigmentation disorders and angiogenic skin disorders, and in processes of treatment and/or care of the skin and/or mucous membranes.

Abstract: Disclosed is a self-reversible reverse latex including: a) 25-80% by mass of a cross-linked anionic polyelectrolyte (P), resulting from the polymerisation, for 100 mole percent: i)—of a molar proportion 30% and 95% of monomeric units from at least one monomer including a free, partially- or totally-salified strong acid function; and ii)—of a molar proportion >0% and <5% of at least one monomer with diethylenic or polyethylenic crosslinking; b) 0.5-10% by mass of a terpolymer of stearyl methacrylate, pentacosaethoxylated behenyl methacrylate and N,N-dimethylacrylamide, resulting from the polymerisation, for 100 mole percent: of 80-95 mole percent of stearyl methacrylate, of 2.5-10 mole percent of N,N-dimethylacrylamide, and of 2.5-10 mole percent of pentacosaethoxylated behenyl methacrylate, c) 5-40% by mass of at least one oil, and d) 0.1-40% by mass of water; method of preparing same and use thereof as a thickener.

Abstract: Compounds of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-AA7-Yp—Zq—R2, their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, preparation processes, cosmetic or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, neurological, compulsive and/or neuropsychiatric diseases and/or disorders and in processes of treatment and/or care of the skin, hair and/or mucous membranes mediated by neuronal exocytosis.

Abstract: Products and methods are disclosed for reducing the production of unwanted odors on the human body.

Abstract: The present invention relates to an Achillea essential oil comprising at least the following compounds, each preferably present in a proportion of at least 5% by weight, with respect to the total weight of the essential oil: artemisia ketone and chrys anthenone (two combined isomers). The invention also relates to a cosmetic composition comprising the said Achillea essential oil and to its cosmetic use as antidandruff agent or as deodorant active agent.

Abstract: An antiperspirant or deodorant composition comprising i) an antiperspirant or deodorant active, ii) a liquid carrier for the antiperspirant or deodorant active, and iii) fragrance in which the fragrance comprises a mixture of first and second fragrances, respectively (iiia) and (iiib), the first fragrance (iiia) being free from encapsulation and comprising fragrance components having a boiling point of higher than 250° C. at 1 bar pressure in a weight proportion of greater than 65% and the second fragrance (iiib) being encapsulated in a water-insoluble shear-sensitive encapsulating material and comprising fragrance components having a boiling point of greater than 250° C. at 1 bar pressure in a weight proportion of less than 65%.

Abstract: Liners are adapted for use with a prosthetic or orthotic device, and provide a barrier and/or interface between a residual limb and a prosthetic socket, or between an orthotic device and the site of application. The prosthetic and orthotic liners include at least one antiperspirant, and methods of forming the same in an efficient, reliable manner. The liners may include aluminum-based antiperspirants such as Aluminum Zirconium Tetrachlorohydrex Glycine. The antiperspirants may be provided as a powder or anhydride, may first be constituted in a silicone-oil, and mixed under vacuum. The antiperspirant-oil mixture can be combined with silicone components and mixed under vacuum. The resulting complete mixture is then cast and cured into a silicone elastomer liner with antiperspirant dispersed and/or embedded.

Abstract: A reversely thermo-reversible hydrogel composition comprising a water soluble block copolymer comprising at least two blocks of polyethylene oxide and at least one block of polypropylene oxide, and at least one associative gelling adjuvant having water solubility less than 0.5 g/100 ml, preferably less than 0.3 g/100 ml at 20° C., and being capable of forming water soluble inter-molecular complexes with the water soluble block copolymer in water. The hydrogel composition exhibits improved gelling efficiency, enhanced solubility and/or stability for water sparely soluble and insoluble pharmaceutical agents. The hydrogel compositions are useful in a variety of pharmaceutical and cosmetic products and applications, such as esophageal, otic, vaginal, rectal, ophthalmic, treatments of disorders and imperfections of the skin, and treating and/or preventing alopecia and restoring and/or promoting hair growth.

Abstract: Compounds of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 (I) their stereoisomers, mixtures thereof, their cosmetically or pharmaceutically acceptable salts and/or its functionally equivalent variants, preparation processes, cosmetic or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, neurological, compulsive and/or neuropsychiatric diseases and/or disorders and in processes of treatment and/or care of the skin, hair and/or mucous membranes mediated by neuronal exocytosis.

Abstract: Personal care formulations containing alkyl ketal esters having the structure wherein a is 0 or an integer of 1 to 12; b is 0 or 1; R2 is a divalent C1-8 group optionally substituted with up to 5 hydroxyl groups; and R1 is C1-6 alkyl.

Abstract: An oil in water emulsion that has a water phase and an oil phase. The water phase includes greater than about 0.5% of the salt form of a neutralized acid, the acid being preferably salicylic acid; and, from about 2% to about 0.001%, by weight of a gum. The oil in water emulsion is stable, that is, it is substantially unaltered in chemical state and physical homogeneity, upon exposure to 14 days at a temperature & humidity of about 50° C. and 60% RH. The gum is preferably xanthan gum, and the emulsion may include from about 0.01 to about 10%, of an emulsifier.

Abstract: The invention relates to hydrocarbon mixtures containing the 14C isotope, use thereof and cosmetic and/or pharmaceutical preparations comprising hydrocarbon mixtures containing the 14C isotope.